Lung cancer drug therapy in Hungary – 3-year experience

per Moldvay, Judit, Rokszin, György, Abonyi-Tóth, Zsolt, Katona, Lajos, Fábián, Katalin, Kovács, Gábor
Publicat a Onco Targets Ther (2015)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

per Lohinai, Zoltan, Klikovits, Thomas, Moldvay, Judit, Ostoros, Gyula, Raso, Erzsebet, Timar, Jozsef, Fabian, Katalin, Kovalszky, Ilona, Kenessey, István, Aigner, Clemens, Renyi-Vamos, Ferenc, Klepetko, Walter, Dome, Balazs, Hegedus, Balazs
Publicat a Sci Rep (2017)

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metasta...

per Téglási, Vanda, Reiniger, Lilla, Fábián, Katalin, Pipek, Orsolya, Csala, Irén, Bagó, Attila G., Várallyai, Péter, Vízkeleti, Laura, Rojkó, Lívia, Tímár, József, Döme, Balázs, Szállási, Zoltán, Swanton, Charles, Moldvay, Judit
Publicat a Neuro Oncol (2017)

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers

per Aldon, Yoann, McKay, Paul F., Allen, Joel, Ozorowski, Gabriel, Felfödiné Lévai, Réka, Tolazzi, Monica, Rogers, Paul, He, Linling, de Val, Natalia, Fábián, Katalin, Scarlatti, Gabriella, Zhu, Jiang, Ward, Andrew B., Crispin, Max, Shattock, Robin J.
Publicat a Cell Rep (2018)